NFE2L2 and obesity disorder: Pharmacologic or systemic genetic activation of the NRF2 pathway (e.g., Kp1A/A hypomorphic) partially protects mice fed a high-fat diet (60% kcal fat versus 10%) from obesity and insulin resistance [15,16].